Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma

NCT01381705 · clinicaltrials.gov ↗

COMPLETED

Status

259

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
GENETIC: DNA analysis
GENETIC: gene expression analysis
GENETIC: polymorphism analysis
OTHER: laboratory biomarker analysis
OTHER: medical chart review

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]